Literature DB >> 20869315

Drug interactions in childhood cancer.

Cyrine Haidar1, Sima Jeha.   

Abstract

Children with cancer are increasingly benefiting from new treatment strategies and advances in supportive care, as shown by improvements in both survival and quality-of-life. However, the continuous emergence of new cancer drugs and supportive-care drugs has increased the possibility of harmful drug interactions; health-care providers need to be very cautious when combining drugs. We discuss the most common interactions between chemotherapeutic drugs and supportive-care drugs-such as anticonvulsants, antiemetics, uric-acid-lowering compounds, acid suppressants, antimicrobials, and pain-management medications in paediatric patients. We also review the interactions between chemotherapy drugs and food and herbal supplements, and provide recommendations to avoid unwanted and potentially fatal interactions in children with cancer. Because of the constant release of new drugs, health-care providers need to check the most recent references before making recommendations about drug interactions. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869315      PMCID: PMC4865887          DOI: 10.1016/S1470-2045(10)70105-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  70 in total

1.  Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone.

Authors:  Jacqueline B McCrea; Anup K Majumdar; Michael R Goldberg; Marian Iwamoto; Cynthia Gargano; Deborah L Panebianco; Michael Hesney; Christopher R Lines; Kevin J Petty; Paul J Deutsch; M Gail Murphy; Keith M Gottesdiener; D Ronald Goldwater; Robert A Blum
Journal:  Clin Pharmacol Ther       Date:  2003-07       Impact factor: 6.875

2.  Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.

Authors:  Masahide Fukudo; Ikuko Yano; Satohiro Masuda; Maki Goto; Miwa Uesugi; Toshiya Katsura; Yasuhiro Ogura; Fumitaka Oike; Yasutsugu Takada; Hiroto Egawa; Shinji Uemoto; Ken-ichi Inui
Journal:  Clin Pharmacol Ther       Date:  2006-10       Impact factor: 6.875

Review 3.  Itraconazole-related increased vincristine neurotoxicity: case report and review of literature.

Authors:  Mar Bermúdez; Jose Luis Fuster; Esther Llinares; Ana Galera; Celia Gonzalez
Journal:  J Pediatr Hematol Oncol       Date:  2005-07       Impact factor: 1.289

4.  Inhibition of urate production by allopurinol.

Authors:  T Spector
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

5.  The influence of aminoglycosides on the nephrotoxicity of cis-diamminedichloroplatinum in cancer patients.

Authors:  A Haas; L Anderson; T Lad
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

6.  Effect of grapefruit juice intake on etoposide bioavailability.

Authors:  Stefanie Reif; Marianne C Nicolson; Donald Bisset; Muriel Reid; Charlotte Kloft; Ulrich Jaehde; Howard L McLeod
Journal:  Eur J Clin Pharmacol       Date:  2002-09-03       Impact factor: 2.953

7.  Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.

Authors:  Alain J Romero; Patrick Le Pogamp; Lars-Goran Nilsson; Nolan Wood
Journal:  Clin Pharmacol Ther       Date:  2002-04       Impact factor: 6.875

8.  Patient characteristics associated with high-risk methotrexate concentrations and toxicity.

Authors:  M V Relling; D Fairclough; D Ayers; W R Crom; J H Rodman; C H Pui; W E Evans
Journal:  J Clin Oncol       Date:  1994-08       Impact factor: 44.544

9.  Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.

Authors:  S Fanta; S Jönsson; J T Backman; M O Karlsson; K Hoppu
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

10.  Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouse.

Authors:  D S Alberts; Y M Peng; H S Chen; R F Struck
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

View more
  10 in total

Review 1.  Azole interactions with multidrug therapy in pediatric oncology.

Authors:  Antonio Ruggiero; Roberta Arena; Andrea Battista; Daniela Rizzo; Giorgio Attinà; Riccardo Riccardi
Journal:  Eur J Clin Pharmacol       Date:  2012-06-02       Impact factor: 2.953

2.  Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.

Authors:  Yin Ting Cheung; Kevin R Krull
Journal:  Neurosci Biobehav Rev       Date:  2015-04-07       Impact factor: 8.989

3.  SAR Studies on Aromatic Acylhydrazone-Based Inhibitors of Fungal Sphingolipid Synthesis as Next-Generation Antifungal Agents.

Authors:  Krupanandan Haranahalli; Cristina Lazzarini; Yi Sun; Julia Zambito; Senuri Pathiranage; J Brian McCarthy; John Mallamo; Maurizio Del Poeta; Iwao Ojima
Journal:  J Med Chem       Date:  2019-08-16       Impact factor: 7.446

4.  Evaluation of utility of pharmacokinetic studies in phase I trials of two oncology drugs.

Authors:  Kehua Wu; Larry House; Jacqueline Ramírez; Michael J Seminerio; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2013-09-20       Impact factor: 12.531

5.  High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey.

Authors:  Maartje Singendonk; Gert-Jan Kaspers; Marianne Naafs-Wilstra; Antoinette Schouten-van Meeteren; Jan Loeffen; Arine Vlieger
Journal:  Eur J Pediatr       Date:  2012-09-19       Impact factor: 3.183

Review 6.  Role of CAR and PXR in xenobiotic sensing and metabolism.

Authors:  Yue-Ming Wang; Su Sien Ong; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-05-03       Impact factor: 4.481

7.  Analysis of Clinical Profile and Outcome of Tuberculosis in Patients with Acute Leukemia.

Authors:  Arihant Jain; Gaurav Prakash; Charanpreet Singh; Deepesh Lad; Alka Khadwal; Vikas Suri; Pankaj Malhotra; Savita Kumari; Neelam Varma; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-12       Impact factor: 0.900

8.  Potential drug-drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study.

Authors:  Paula Stoll; Luciane Kopittke
Journal:  Int J Clin Pharm       Date:  2015-02-25

9.  Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.

Authors:  M Angeles Fernández de Palencia Espinosa; M Sacramento Díaz Carrasco; José Luis Fuster Soler; Guadalupe Ruíz Merino; M Amelia De la Rubia Nieto; Alberto Espuny Miró
Journal:  Int J Clin Pharm       Date:  2014-09-10

10.  Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment.

Authors:  Emmanuelle Lüthi; Manuel Diezi; Nadia Danon; Julie Dubois; Jérôme Pasquier; Bernard Burnand; Pierre-Yves Rodondi
Journal:  BMC Complement Med Ther       Date:  2021-03-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.